Every three seconds, someone in the world develops dementia. Alzheimer's disease is the most common form of dementia, accounting for between 60% and ...

Severe autoimmune-mediated neuropathies, such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and ...

The debate between CAR T-cell therapy and bispecific antibodies is not a rivalry but a question of sequencing, ...

SPY002 and SPY072 were well tolerated, exhibited PK that supports quarterly or less frequent dosing, and fully engaged TL1A through up to 20 weeks of follow-up; ~75 ...

Researchers identify small llama-derived antibodies that neutralize multiple coronaviruses, targeting a stable region of the spike protein for broad protection.

Powerful llama-derived antibodies could be the key to stopping not just current SARS viruses, but future ones too. Scientists ...

The combo therapy demonstrated an ORR of 87%, with a complete response rate of 65% and a partial response rate of 23%.

Researchers at the Olivia Newton-John Cancer Research Institute and collaborators have developed a new anti-HER2 monoclonal antibody, mAb104, which targets a conformationally exposed, tumor-specific ...

Abstract: Learning-based perception systems in robotics often requires large-scale image segmentation annotation. Current approaches rely on human labelers, which can be expensive, or simulation data, ...

KRAKOW, Poland I June 12, 2025 I Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel therapies that ...